These are the sources and citations used to research responsible. This bibliography was generated on Cite This For Me on

  • Report

    CIPLA PHARMACEUTICAL COMPANY

    Caring For Life since 1935

    2020 - Cipla

    In-text: (CIPLA PHARMACEUTICAL COMPANY, 2020)

    Your Bibliography: CIPLA PHARMACEUTICAL COMPANY, 2020. Caring For Life since 1935. ANNUAL REPORT 2019-20. [online] Cipla. Available at: <https://www.cipla.com/sites/default/files/2020-08/CIpla-AR-2019-20.pdf> [Accessed 1 January 2022].

  • Website

    Cipla enters into a licensing agreement With Gilead to expand access to COVID-19 treatment | Cipla

    2020

    In-text: (Cipla enters into a licensing agreement With Gilead to expand access to COVID-19 treatment | Cipla, 2020)

    Your Bibliography: Cipla.com. 2020. Cipla enters into a licensing agreement With Gilead to expand access to COVID-19 treatment | Cipla. [online] Available at: <https://www.cipla.com/latest-respiratory-article/cipla-enters-licensing-agreement-gilead-expand-access-covid-19-treatment> [Accessed 1 January 2022].

  • Website

    Cipla - Leading pharmaceutical company | Best in industry

    In-text: (Cipla - Leading pharmaceutical company | Best in industry, n.d.)

    Your Bibliography: Cipla.com. n.d. Cipla - Leading pharmaceutical company | Best in industry. [online] Available at: <https://www.cipla.com/about-us> [Accessed 3 January 2022].

  • Journal

    Forman, R., Shah, S., Jeurissen, P., Jit, M. and Mossialos, E.

    COVID-19 vaccine challenges: What have we learned so far and what remains to be done?

    2021 - Health Policy

    In-text: (Forman et al., 2021)

    Your Bibliography: Forman, R., Shah, S., Jeurissen, P., Jit, M. and Mossialos, E., 2021. COVID-19 vaccine challenges: What have we learned so far and what remains to be done?. Health Policy, 125(5), pp.553-567.

  • Govt. publication

    GOVERNMENT OF INDIA MINISTRY OF CHEMICALS & FERTILIZERS DEPARTMENT OF PHARMACEUTICALS

    No.31015/01/2020-Pricing

    2020 - New Dehli

    In-text: (GOVERNMENT OF INDIA MINISTRY OF CHEMICALS & FERTILIZERS DEPARTMENT OF PHARMACEUTICALS, 2020)

    Your Bibliography: GOVERNMENT OF INDIA MINISTRY OF CHEMICALS & FERTILIZERS DEPARTMENT OF PHARMACEUTICALS, 2020. No.31015/01/2020-Pricing. New Dehli.

  • Website

    IBEF and India, P.

    Cipla Ltd: About Cipla Pharma, Company Profile, Products, Solutions...IBEF | IBEF

    In-text: (IBEF and India, n.d.)

    Your Bibliography: IBEF and India, P., n.d. Cipla Ltd: About Cipla Pharma, Company Profile, Products, Solutions...IBEF | IBEF. [online] Ibef.org. Available at: <https://www.ibef.org/industry/pharmaceutical-india/showcase/cipla-limited> [Accessed 4 January 2022].

  • Website

    Lo, C.

    Cost control: drug pricing policies around the world

    2018

    In-text: (Lo, 2018)

    Your Bibliography: Lo, C., 2018. Cost control: drug pricing policies around the world. [online] Pharmaceutical Technology. Available at: <https://www.pharmaceutical-technology.com/features/cost-control-drug-pricing-policies-around-world/> [Accessed 3 January 2022].

  • Website

    Drug Pricing: Don't Take Coercive Steps Against Cipla, Others, Says Court

    2015

    In-text: (Drug Pricing: Don't Take Coercive Steps Against Cipla, Others, Says Court, 2015)

    Your Bibliography: NDTV.com. 2015. Drug Pricing: Don't Take Coercive Steps Against Cipla, Others, Says Court. [online] Available at: <https://www.ndtv.com/business/drug-pricing-dont-take-coercive-steps-against-cipla-others-says-court-1247213> [Accessed 3 January 2022].

  • Website

    Drug firms facing challenging times due to price control: Cipla

    2016

    In-text: (Drug firms facing challenging times due to price control: Cipla, 2016)

    Your Bibliography: The Economic Times. 2016. Drug firms facing challenging times due to price control: Cipla. [online] Available at: <https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/drug-firms-facing-challenging-times-due-to-price-control-cipla/articleshow/54584155.cms> [Accessed 3 January 2022].

  • Journal

    Urias, E. and Ramani, S. V.

    Access to medicines after TRIPS: Is compulsory licensing an effective mechanism to lower drug prices? A review of the existing evidence

    2020 - Journal of International Business Policy

    In-text: (Urias and Ramani, 2020)

    Your Bibliography: Urias, E. and Ramani, S., 2020. Access to medicines after TRIPS: Is compulsory licensing an effective mechanism to lower drug prices? A review of the existing evidence. Journal of International Business Policy, 3(4), pp.367-384.

Click here to start building your own bibliography
Keep on Citing!
Cite This For Me:
The Easiest Tool to Create your Bibliographies Online
Join Us!

Save Time and Improve Your Marks with Cite This For Me

10,587 students joined last month!

  • ✔ Save your bibliographies for longer
  • ✔ Quick and accurate citation program
  • ✔ Save time when referencing
  • ✔ Make your student life easy and fun
  • ✔ Pay only once with our Forever plan
  • ✔ Use plagiarism checker
  • ✔ Create and edit multiple bibliographies
Join